K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

Neurobiology of Disease

Volumn 47, Issue 2, 2012, Pages 280-293

  Jukkola, Peter I ^a   Lovett Racke, Amy E ^a   Zamvil, Scott S ^b   Gu, Chen ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

4 AminoPyridine (4 AP); Astrocyte; Experimental autoimmune encephalomyelitis (EAE); Myelin; Spinal cord; Voltage gated potassium (Kv) channel

Indexed keywords

4 AMINOPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL FUNCTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; MOTONEURON; MOUSE; MYELINATED NERVE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; SPINAL CORD; SYNAPTIC TRANSMISSION; UPREGULATION;

ANIMALS; CELLS, CULTURED; DENDRITES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; KV1.2 POTASSIUM CHANNEL; KV1.4 POTASSIUM CHANNEL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RATS; SEVERITY OF ILLNESS INDEX;

EID: 84861668121     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.04.012     Document Type: Article

References (70)

1. Aharoni R., Vainshtein A., Stock A., Eilam R., From R., Shinder V., Arnon R. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J. Autoimmun. 2011, 37:228-241.
2. Attali B., Wang N., Kolot A., Sobko A., Cherepanov V., Soliven B. Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J. Neurosci. 1997, 17:8234-8245.
3. Barry J., Gu Y., Gu C. Polarized targeting of L1-CAM regulates axonal and dendritic bundling in vitro. Eur. J. Neurosci. 2010, 32:1618-1631.
4. Beeton C., Chandy K.G. Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 2005, 11:550-562.
5. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 2004, 25:280-289.
6. Chittajallu R., Chen Y., Wang H., Yuan X., Ghiani C.A., Heckman T., McBain C.J., Gallo V. Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2350-2355.
7. Cooper E.C., Milroy A., Jan Y.N., Jan L.Y., Lowenstein D.H. Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus. J. Neurosci. 1998, 18:965-974.
8. Debanne D. Information processing in the axon. Nat. Rev. Neurosci. 2004, 5:304-316.
9. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
10. Edwards L., Nashmi R., Jones O., Backx P., Ackerley C., Becker L., Fehlings M.G. Upregulation of Kv 1.4 protein and gene expression after chronic spinal cord injury. J. Comp. Neurol. 2002, 443:154-167.
11. Espejo C., Montalban X. Dalfampridine in multiple sclerosis: from symptomatic treatment to immunomodulation. Clin. Immunol. 2012, 142:84-92.
12. Farber K., Kettenmann H. Physiology of microglial cells. Brain Res. Brain Res. Rev. 2005, 48:133-143.
13. Fordyce C.B., Jagasia R., Zhu X., Schlichter L.C. Microglia Kv1.3 channels contribute to their ability to kill neurons. J. Neurosci. 2005, 25:7139-7149.
14. Garcia A.D., Doan N.B., Imura T., Bush T.G., Sofroniew M.V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 2004, 7:1233-1241.
15. Goodman A.D., Brown T.R., Krupp L.B., Schapiro R.T., Schwid S.R., Cohen R., Marinucci L.N., Blight A.R. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009, 373:732-738.
16. Goodman A.D., Brown T.R., Edwards K.R., Krupp L.B., Schapiro R.T., Cohen R., Marinucci L.N., Blight A.R. A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann. Neurol. 2010, 68:494-502.
17. Gu C., Barry J. Function and mechanism of axonal targeting of voltage-sensitive potassium channels. Prog. Neurobiol. 2011, 94:115-132.
18. Gu Y., Gu C. Dynamics of Kv1 channel transport in axons. PLoS One 2010, 5:e11931.
19. Gu C., Gu Y. Clustering and activity tuning of Kv1 channels in myelinated hippocampal axons. J. Biol. Chem. 2011, 286:25835-25847.
20. Gu Y., Barry J., McDougel R., Terman D., Gu C. Alternative splicing regulates Kv3.1 polarized targeting to adjust maximal spiking frequency. J. Biol. Chem. 2012, 287:1755-1769.
21. Guo F., Maeda Y., Ma J., Delgado M., Sohn J., Miers L., Ko E.M., Bannerman P., Xu J., Wang Y., Zhou C., Takebayashi H. Pleasure D macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J. Neurosci. 2011, 31:11914-11928.
22. Hayes K.C. The use of 4-aminopyridine (fampridine) in demyelinating disorders. CNS Drug Rev. 2004, 10:295-316.
23. Herrero-Herranz E., Pardo L.A., Bunt G., Gold R., Stuhmer W., Linker R.A. Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation. Am. J. Pathol. 2007, 171:589-598.
24. Hille B. Ion channels of excitable membranes. Sinauer, Sunderland, Massachusetts, 2001 2001.
25. Hodgkin A.L., Huxley A.F. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J. Physiol. 1952, 116:449-472.
26. Judge S.I., Bever C.T. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol. Ther. 2006, 111:224-259.
27. Kettenmann H., Banati R., Walz W. Electrophysiological behavior of microglia. Glia 1993, 7:93-101.
28. Kornek B., Storch M.K., Bauer J., Djamshidian A., Weissert R., Wallstroem E., Stefferl A., Zimprich F., Olsson T., Linington C., Schmidbauer M., Lassmann H. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001, 124:1114-1124.
29. + channel in hippocampal neurons. Neuron 2000, 25:385-397.
30. Lublin F.D., Lavasa M., Viti C., Knobler R.L. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. Clin. Immunol. Immunopathol. 1987, 45:122-128.
31. Misonou H., Mohapatra D.P., Park E.W., Leung V., Zhen D., Misonou K., Anderson A.E., Trimmer J.S. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat. Neurosci. 2004, 7:711-718.
32. Misonou H., Menegola M., Mohapatra D.P., Guy L.K., Park K.S., Trimmer J.S. Bidirectional activity-dependent regulation of neuronal ion channel phosphorylation. J. Neurosci. 2006, 26:13505-13514.
33. Muennich E.A., Fyffe R.E. Focal aggregation of voltage-gated, Kv2.1 subunit-containing, potassium channels at synaptic sites in rat spinal motoneurones. J. Physiol. 2004, 554:673-685.
34. Nikic I., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M., Bruck W., Bishop D., Misgeld T., Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 2011, 17:495-499.
35. Nutile-McMenemy N., Elfenbein A., Deleo J.A. Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression. J. Neurochem. 2007, 103:2035-2046.
36. + channel. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12351-12356.
37. Ogawa Y., Oses-Prieto J., Kim M.Y., Horresh I., Peles E., Burlingame A.L., Trimmer J.S., Meijer D., Rasband M.N. ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J. Neurosci. 2010, 30:1038-1048.
38. Pannasch U., Farber K., Nolte C., Blonski M., Yan Chiu S., Messing A., Kettenmann H. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. Mol. Cell. Neurosci. 2006, 33:401-411.
39. Rasband M.N., Shrager P. Ion channel sequestration in central nervous system axons. J. Physiol. 2000, 525(Pt 1):63-73.
40. Rasband M.N., Trimmer J.S., Schwarz T.L., Levinson S.R., Ellisman M.H., Schachner M., Shrager P. Potassium channel distribution, clustering, and function in remyelinating rat axons. J. Neurosci. 1998, 18:36-47.
41. + channel distribution and clustering in developing and hypomyelinated axons of the optic nerve. J. Neurocytol. 1999, 28:319-331.
42. Rasband M.N., Park E.W., Vanderah T.W., Lai J., Porreca F., Trimmer J.S. Distinct potassium channels on pain-sensing neurons. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13373-13378.
43. + channel alpha- and beta-subunit polypeptides in rat brain. J. Neurosci. 1995, 15:5360-5371.
44. + channel complexes. J. Neurosci. 1997, 17:8246-8258.
45. Seri B., Garcia-Verdugo J.M., McEwen B.S., Alvarez-Buylla A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J. Neurosci. 2001, 21:7153-7160.
46. + channel proteins in rat central neurons. Neuron 1992, 9:271-284.
47. + channels. J. Neurophysiol. 2006, 95:1683-1695.
48. Slavin A., Kelly-Modis L., Labadia M., Ryan K., Brown M.L. Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity 2010, 43:504-513.
49. Sontheimer H., Waxman S.G. Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types. J. Neurophysiol. 1992, 68:1001-1011.
50. +-ATPase activity. J. Neurosci. 1994, 14:2464-2475.
51. Steinman L. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat. Rev. Drug Discov. 2005, 4:510-518.
52. Trimmer J.S., Rhodes K.J. Localization of voltage-gated ion channels in mammalian brain. Annu. Rev. Physiol. 2004, 66:477-519.
53. Vabnick I., Trimmer J.S., Schwarz T.L., Levinson S.R., Risal D., Shrager P. Dynamic potassium channel distributions during axonal development prevent aberrant firing patterns. J. Neurosci. 1999, 19:747-758.
54. Vacher H., Mohapatra D.P., Trimmer J.S. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol. Rev. 2008, 88:1407-1447.
55. Vogt J., Paul F., Aktas O., Muller-Wielsch K., Dorr J., Dorr S., Bharathi B.S., Glumm R., Schmitz C., Steinbusch H., Raine C.S., Tsokos M., Nitsch R., Zipp F. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann. Neurol. 2009, 66:310-322.
56. + channels in terminal and juxtaparanodal regions of neurons. Nature 1993, 365:75-79.
57. Wang H., Kunkel D.D., Schwartzkroin P.A., Tempel B.L. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J. Neurosci. 1994, 14:4588-4599.
58. + channel expression in mouse mutants shiverer and trembler. Neuron 1995, 15:1337-1347.
59. Waxman S.G. Membranes, myelin, and the pathophysiology of multiple sclerosis. New Engl. J Med 1982, 306:1529-1533.
60. Waxman S.G. Ion channels and neuronal dysfunction in multiple sclerosis. Arch. Neurol. 2002, 59:1377-1380.
61. Waxman S.G. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 2006, 7:932-941.
62. Wu C.Y., Kaur C., Sivakumar V., Lu J., Ling E.A. Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide. Neuroscience 2009, 158:1500-1508.
63. Wulff H., Beeton C., Chandy K.G. Potassium channels as therapeutic targets for autoimmune disorders. Curr. Opin. Drug Discov. Devel. 2003, 6:640-647.
64. + channel in effector memory T cells as new target for MS. J. Clin. Invest. 2003, 111:1703-1713.
65. Xu M., Cao R., Xiao R., Zhu M.X., Gu C. The axon-dendrite targeting of Kv3 (Shaw) channels is determined by a targeting motif that associates with the T1 domain and ankyrin G. J. Neurosci. 2007, 27:14158-14170.
66. Xu M., Gu Y., Barry J., Gu C. Kinesin I transports tetramerized Kv3 channels through the axon initial segment via direct binding. J. Neurosci. 2010, 30:15987-16001.
67. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420:78-84.
68. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990, 8:579-621.
69. Zhou L., Zhang C.L., Messing A., Chiu S.Y. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J. Neurosci. 1998, 18:7200-7215.
70. Zhu B., Luo L., Moore G.R., Paty D.W., Cynader M.S. Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am. J. Pathol. 2003, 162:1639-1650.